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1. Introduction
The relationship between atrial fibrillation (AF) and coffee is
controversial, although it carries important clinical implica-
tions due to the fact that caffeine is one of the most widely
consumed active substances in the world and that AF is the
most common arrhythmia in adults. The major intake of caf-
feine in adults comes from coffee, whereas young people
consume caffeine in beverages like cola soda and energy
drinks (EDs) [1,2].
The estimated caffeine from coffee consumption in the
Mediterranean area is about 198 mg/day per person, similar
to the 210 mg/day reported in the USA [2].
It is important to distinguish between coffee and caffeine
effects. Caffeine exerts a stimulating effect on the heart,
increasing cardiac contractility and stroke volume. Coronary
vessels dilate while brain vessels constrict and blood flow to
the brain decreases [1].
Coffee, additionally to caffeine, contains many different
substances, including high levels of phenolic antioxidants con-
sisting principally of chlorogenic acids (CGAs). The total con-
tent of CGA in a ‘regular’ cup of coffee (200 mL) varies
between 70 and 350 mg [2]. Therefore, if coffee is consumed
throughout the day, it may provide up to two thirds of total
daily dietary antioxidants [3].
The most recent approach to cardiovascular disease pre-
vention underline the critical role of lifestyle, nutrition, and
physical activity. Core components of a healthy diet include
limiting intakes of saturated and trans fats, carbohydrate,
alcohol, and sodium and high intakes of fruit, vegetables,
(rich in antioxidants) and dietary fibers. The Mediterranean
Diet meets these healthy diet requirements. The very recent
Mediterranean Diet pyramid included at the basis the physical
activity as well as moderate consumption of both coffee and
wine [4–6].
2. How can it be that coffee and caffeine have been
related to arrhythmias?
Caffeine-rich beverages have been traditionally considered the
main driving environmental factor implicated in a variety of
ordinary but unspecific symptoms (like palpitations and
heartbeat irregularities) in clinical practice. Physicians are par-
ticularly worried that these symptoms might be mediated by
potentially dangerous arrhythmic events.
Hansson et al. found that the 25% of patients regard coffee
as a triggering-factor for arrhythmia [7].
However studies evaluating caffeine effects on supraventri-
cular and ventricular ectopic beats are not linking caffeine
dosage with development of arrhythmias.
In a recent meta-analysis, evaluating caffeine effects on
ventricular arrhythmias, the overall relative risk for occurrence
of ventricular premature beats in 24 h attributed to caffeine
exposure was 1.00 (95% CI 0.94–1.06; P n.s.). Sensitivity analy-
sis for caffeine dose, different designs, and subject profile was
performed and no major differences were observed [8].
The authors concluded that there is no scientific evidence
that supports a clinical recommendation to decrease or avoid
caffeine consumption in patients at risk or with suspicious
symptoms of arrhythmias. Similarly, prospective clinical trials
did not demonstrate an increase in clinically significant ven-
tricular or supraventricular arrhythmias, even after exposure to
high doses of caffeine [9].
The Danish Diet, Cancer and Healthy suggested that caf-
feine consumption was not associated with hospitalizations
for AF in a population with high caffeine intake [10].
Moreover, a recent analysis of the Danish Cohort after
a median follow-up of 13.5 years found that compared with
no intake, coffee consumption was inversely associated with
AF incidence, with multivariable-adjusted hazard ratios of 0.93
for more than none to <1 cup/day, 0.88 for 1 cup/day, 0.86 for
2–3 cups/day, 0.84 for 4–5 cups/day, 0.79 for 6–7 cups/day,
and 0.79 for >7 cups/day (p-linear trend = 0.02). Results
suggested that higher levels of coffee consumption were
associated with a lower rate of incident AF [11].
Similarly, in the Women’s Health Study, caffeine consump-
tion was not associated with an increased risk of incident AF in
middle-aged women. Women in the highest quintile of caf-
feine consumption had a similar risk of developing AF com-
pared with women in the lowest quintile [12].
Larsson et al. summarized the current evidence on the
relationship between regular coffee and new onset AF and
found no significant relationship between coffee intake and
incident AF [13]. Of the six studies, one of them showed
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a statistically significant reduced risk of AF when comparing
the highest with the lowest category of coffee consumption,
but there was no dose–response relationship [13].
When results from all studies were combined, the RR of AF
comparing the highest with the lowest category of coffee
consumption was 0.96 (95% CI 0.84–1.08).
In a sensitive analysis, which included six studies of coffee
consumption and two studies of caffeine intake in relation to AF
risk, the overall RR for the highest versus lowest category of coffee
or caffeine intake was 0.95 (95% CI, 0.86–1.06; I2 = 46.3 %). There
was no evidence of a nonlinear relationship between coffee con-
sumption and AF risk. The RR per 2-cups/d increment of coffee
consumption was 0.99 [13].
Cheng and coworkers showed that the risk of developing
AF decreases by 6% for each increase of habitual intake of
300 mg of coffee, leading to consider that usual intake of
caffeine may even be protective against arrhythmic outcomes.
They suggested that habitual caffeine consumption might
reduce AF risk by its anti-fibrosis effect [14].
At last, the protective effect of caffeine might be related to co-
occurring phytochemicals because caffeine is normally consumed
in the form of plant-derived products and extracts that invariably
contain other potentially bioactive phytochemicals [15].
In conclusion, caffeine exposure based solely on coffee
consumption seems to not influence the risk of AF.
3. The new frontier: caffeine from EDs
Evidence from clinical studies suggests that caffeine might not
be arrhythmogenic in most contexts except in special circum-
stances and at very high doses, and very high doses are
included in EDs [16,17]. Several case reports suggest
a trigger effect of these beverages on arrhythmias [17].
Caffeine toxicity produces supraventricular tachycardia, AF,
and ventricular fibrillation [1,2].
EDs were originally conceived for athletes, to combat fati-
gue, but nowadays, young adults and teenagers represent
their new main market segment.
Caffeine is a widely used energetic substance and many
papers suggested great effects during endurance activities.
A systematic review was carried out on randomized placebo-
controlled studies investigating the effects of caffeine on endur-
ance performance and a meta-analysis was conducted to deter-
mine the ergogenic effect of caffeine on endurance time-trial
performance. Caffeine showed a small but evident effect on
endurance performance when taken in moderate doses
(3–6 mg/kg). Similarly an overall improvement following caffeine
compared to placebo in mean power output (3.03 ± 3.07%; effect
size = 0.23 ± 0.15) and time-trial completion time (2.22 ± 2.59%;
effect size = 0.41 ± 0.2) was reported. However, differences in
responses to caffeine ingestion have been shown, with two stu-
dies reporting slower time-trial performance, while five studies
reported lower mean power output during the time-trial [18].
Consumption of EDs by young people has increased drama-
tically in recent years in order to improve their physical and
psychological performance [18–20]. The literature shows contra-
dictions about the capacity of EDs to enhance psychophysical
results. These drinks are very diffuse within young people
because they are sold in cans, are unrestricted and marketing
campaign identify it as safe products able to improve the
physical and mental performance [19].
Currently, there is not a basic formula or ingredient included
in commercial EDs. However, there are a number of substances,
i.e. methylxanthines, often present in high quantities that give
the beverage psychostimulants characteristics [17]. The EDs con-
tain caffeine, taurine, creatine, carnitine, B vitamins,maltodextrin,
inositol, and glucuronolactone; there are also herbs such as
guarana (containing caffeine), ginseng, and ginkgo biloba [19].
The guarana plant and berry has one of the naturally high-
est levels of caffeine and there are also traces of theophylline
and theobromine.
Being a working student was significantly positively asso-
ciated both to EDs (OR 1.5) and ginseng use (OR 1.4). The most
frequently reported academic and other reasons for ED use
were: ‘to study longer’ (47.5%), and ‘to socialize’ (29.1%). The
most often used combinations were ED containing alcohol
(65.6%) and ginseng-coffee beverages (71.8%) [20].
A paper described the cases of two boys (14 and 16 years
old) without previous cardiac event that developed AF after
consuming EDs [20]. The first boy developed palpitations and
chest pain after taking an ED containing high dose of caffeine.
The same symptoms had been warned five days before having
consumed another popular EDs. The second boy experienced
vomiting, attention problems, hyperactivity, asthma, and chest
pain after taking a mix of EDs, spirits, and vodka, together with
amphetamines. Mattioli et al. also reported cases of AF devel-
oped after ingestion of EDs [17,19].
With the increasing popularity of EDs in the young popula-
tion, physicians should be aware of the arrhythmogenic poten-
tial associated with highly caffeinated beverage consumption.
The FDA is considering new regulation of these beverages, but
product specificity is needed to evaluate safety.
In conclusion, there is no relationship between coffee con-
sumption and arrhythmias, however concern exists about the
fast expansion of highly caffeinated beverages consumption
among young consumers. Highly caffeinated beverages such
as EDs could act as a trigger for arrhythmias. More studies are
needed to explore this specific effect of EDs.
Funding
This paper was not funded.
Declaration of interest
The authors have no relevant affiliations or financial involvement with any
organization or entity with a financial interest in or financial conflict with
the subject matter or materials discussed in the manuscript. This includes
employment, consultancies, honoraria, stock ownership or options, expert
testimony, grants or patents received or pending, or royalties.
Reviewer disclosures
Peer reviewers on this manuscript have no relevant financial or other
relationships to disclose.
ORCID
Anna Vittoria Mattioli http://orcid.org/0000-0003-1487-9530
2 A. V. MATTIOLI
References
Papers of special note have been highlighted as either of interest (•) or of
considerable interest (••) to readers.
1. EFSA, Panel on Dietetic Products, Nutrition and Allergies (NDA).
Scientific opinion on the safety of caffeine: safety of caffeine. EFSA
J. 2015;13(5):4102.
•• Opinion paper from the EFSA.
2. Mattioli AV. Effects of caffeine and coffee consumption on cardio-
vascular disease and risk factors. Future Cardiol. 2007;3(2):203–212.
• Comprehensive review on coffee and caffeine effects.
3. Mattioli AV, Miloro C, Pennella S, et al. Adherence to Mediterranean
diet and intake of antioxidants influence spontaneous conversion
of atrial fibrillation. Nutr Metab Cardiovasc Dis. 2013;23(2):115–121.
4. Farinetti A, Zurlo V, Manenti A, et al. Mediterranean Diet and
colorectal cancer. a systematic review. Nutrition. 2017;43-44:83–88.
5. Mattioli AV, Palmiero P, Manfrini O, et al. Mediterranean diet impact
on cardiovascular diseases: a narrative review. J Cardiovasc Med
(Hagerstown). 2017 Dec;18(12):925–935. .
6. Mattioli AV, Coppi F, Migaldi M, et al. Relationship between
Mediterranean diet and asymptomatic peripheral arterial disease
in a population of pre-menopausal women. Nutr Metab Cardiovasc
Dis. 2017 Oct 3;27:985–990. pii: S0939-4753(17)30226-0.
7. Hansson A, Madsen-Härdig B, Olsson SB. Arrhythmia-provoking
factors and symptoms at the onset of paroxysmal atrial fibrillation:
a study based on interviews with 100 patients seeking hospital
assistance. BMC Cardiovasc Disord. 2004 Aug 3;4:13.
8. Zuchinali P, Ribeiro PA, PimentelM, et al. Effect of caffeine on ventricular
arrhythmia: a systematic review andmeta-analysis of experimental and
clinical studies. Europace. 2016 Feb;18(2):257–266. Epub 2015 Oct 5.
9. O’Keefe JH, Bhatti SK, Patil HR, et al. Effects of habitual coffee
consumption on cardio-metabolic disease, cardiovascular health,
and all-cause mortality. J Am Coll Cardiol. 2013;62:1043–1051.
10. Frost L, Vestergaard P. Caffeine and risk of atrial fibrillation or flutter: the
Danish diet, cancer, and health study. Am J Clin Nutr. 2005;81:578–582.
11. Mostofsky E, Johansen MB, Lundbye-Christensen S, et al. Risk of
atrial fibrillation associated with coffee intake: findings from the
Danish diet, cancer, and health study. Eur J Prev Cardiol. 2016
Jun;23(9):922–930. Epub 2015 Dec 23.
12. Conen D, Chiuve SE, Everett BM, et al. Caffeine consumption and
incident atrial fibrillation in women. Am J Clin Nutr. 2010 Sep;92
(3):509–514. Epub 2010 Jun 23.
13. Larsson SC, Drca N, Jensen-Urstad M, et al. Coffee consumption is
not associated with increased risk of atrial fibrillation: results from
two prospective cohorts and a meta-analysis. BMC Med. 2015 Sep
23;13: 207.
14. Cheng M, Hu Z, Lu X, et al. Caffeine intake and atrial fibrillation
incidence: dose response meta-analysis of prospective cohort
studies. Can J Cardiol. 2014;30:448–454.
15. Mattioli AV, Migaldi M, Farinetti A. Coffee in hypertensive women
with asymptomatic peripheral arterial disease: a potential nutra-
ceutical effect. J Cardiovasc Med. 2018;19:183–185.
16. Jabbar SB, Hanly MG. Fatal caffeine overdose: a case report and
review of literature. Am J Forensic Med Pathol. 2013;34(4):321–324.
17. Mattioli AV, Pennella S, Farinetti A, et al. Energy drinks and atrial
fibrillation in young adults. Clin Nutr. 2018;37:1073–1074.
18. Southward K, Rutherfurd-Markwick KJ, Ali A. The effect of acute
caffeine ingestion on endurance performance: a systematic
review and meta-analysis. Sports Med. 2018 Jun 6. DOI:10.1007/
s40279-018-0939-8.
19. Mattioli AV, Pennella S, Manenti A, et al. Energy drink over-
consumption can trigger atrial fibrillation. J Cardiovasc Med.
2016;17:902–903.
20. Majori S, Pilati S, Gazzani D, et al. Energy drink and ginseng con-
sumption by Italian university students: a cross-sectional study.
J Prev Med Hyg. 2018 Mar 30;59(1):E63–E74.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY 3
